Shane Paladin sells EQIX shares under 10b5-1 plans

Shane Paladin reported sales of company common stock under 10b5-1 trading plans.

Rhea-AI Filing Summary

Shane Paladin reported sales of company common stock under 10b5-1 trading plans.

The filing lists two completed 10b5-1 sales: 327 shares on 01/16/2026 for $263,025.00 and 673 shares on 02/18/2026 for $628,557.50. It also lists 208 restricted stock units tied to a sale action dated 03/01/2026.

Insights

Equity Compensation Analyst

Insider sold modest blocks under pre-established 10b5-1 plans; amounts are concrete and routine.

The filing documents two 10b5-1 sales totaling $891,582.50 executed on 01/16/2026 and 02/18/2026, and a separate line showing 208 restricted stock units with a 03/01/2026 action. These entries record transactions rather than corporate changes.

Timing and cash‑flow recipients are explicit in the sale rows; broader impact on outstanding share count or company capitalization is not provided in the excerpt, so materiality to ownership is not determinable from this content.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Shane Paladin report for EQIX?

Shane Paladin reported two 10b5-1 sales: 327 shares on 01/16/2026 for $263,025.00 and 673 shares on 02/18/2026 for $628,557.50. The filing also lists 208 restricted stock units dated 03/01/2026.

Were the sales part of a prearranged trading plan?

Yes. The two executed sales are described as 10b5-1 sales, indicating they were made under pre-established trading plans. The excerpt explicitly labels both completed transactions as 10b5-1 sales.

How much cash did the reported insider sales generate?

The two completed sales generated $263,025.00 and $628,557.50, for an aggregate of $891,582.50 as shown in the excerpt. No proceeds recipient beyond the reporting rows is specified.

What securities were listed for sale on 03/01/2026?

The filing lists Common securities described as Restricted Stock Units with a quantity of 208 and an associated date of 03/01/2026. The entry labels the issuer role as shown in the excerpt.

Does the filing state any impact on outstanding shares or dilution?

The excerpt does not provide shares outstanding, dilution metrics, or comparative ownership figures. It records specific sales quantities and RSUs but does not link them to overall capitalization or dilution percentages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002056547
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EQUINIX INC.
SEC File Number	001-40205
Address of Issuer	One Lagoon Drive Redwood City CALIFORNIA 94065
Phone	6505986000
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL SHANE PALADIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	208	200948.80	98254928	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Restricted Stock Units	Issuer			208	03/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SHANE PALADIN One Lagoon Drive Redwood City CA 94065	COMMON	02/18/2026	673	628557.50
10b5-1 Sales for SHANE PALADIN One Lagoon Drive Redwood City CA 94065	COMMON	01/16/2026	327	263025.00

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Shane Paladin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)